Skin sensitisation

Alternatives to Laboratory Animals

Volumn 33, Issue SUPPL. 1, 2005, Pages 83-103

  Basketter, David ^a   Casati, Silvia ^b   Gerberick, G Frank ^c   Griem, Peter ^d   Philips, Barry ^e   Worth, Andrew ^b  

^a UNILEVER RESEARCH   (United Kingdom)

^b JOINT RESEARCH CENTRE   (Italy)

^c PROCTER AND GAMBLE COMPANY   (United States)

^d CLARIANT PRODUKTE DEUTSCHLAND GMBH   (Germany)

^e Research Animals Department   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COSMETIC; CYTOKINE; INTERLEUKIN 1BETA;

ANIMAL TESTING ALTERNATIVE; ANTIGEN EXPRESSION; BUEHLER GUINEA PIG TEST; CELL CULTURE; CELL LINE; CHEMICAL STRUCTURE; COMPUTER SYSTEM; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DENDRITIC CELL; EAR SWELLING TEST; EPIDERMIS; EXPLANT; HUMAN; HUMAN MAXIMIZATION TEST; IMMUNE RESPONSE; KERATINOCYTE; LANGERHANS CELL; LOCAL LYMPH NODE ASSAY; MAGNUSSON KLOGMAN GUINEA PIG MAXIMIZATION TEST; MARKETING; NONHUMAN; PATCH TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCHWARTZ PECK TEST; SKIN ALLERGY; SKIN PERMEABILITY; SKIN SENSITIZATION; TISSUE CULTURE; TOXICITY TESTING; VALIDATION PROCESS;

ANIMALIA; CAVIA PORCELLUS;

EID: 22844432843     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290503301s10     Document Type: Review

References (119)

1. SCCNFP (2000). The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers Notes of Guidance For Testing of Cosmetic Ingredients For Their Safety Evaluation. Adopted by the SCCNFP during the plenary meeting of 24 October 2000 (SCCNFP/0321/00 Final), 114pp. Brussels, Belgium: DG SANCO/C/2, European Commission.
2. Kimber, I., Mitchell, J.A. & Griffin, A.C. (1986). Development of a murine local lymph node assay for the determination of sensitizing potential. Food and Chemical Toxicology 24, 481-494.
3. Kimber, I., Hilton, J. & Weisenberger, C. (1989). The murine local lymph node assay for identification of contact allergens: a preliminary evaluation of in situ measurement of lymphocyte proliferation. Contact Dermatitis 21, 215-220.
4. Kimber, I., Dearman, R.J., Basketter, D.A., Ryan, C.A. & Gerberick, G.F. (2002). The local lymph node assay: past, present and future. Contact Dermatitis 47, 315-328
5. Sailstad, D.M., Hattan, D., Hill, R.N. & Stokes, W.S. (2001). ICCVAM evaluation of the murine local lymph node assay. I. The ICCVAM review process. Regulatory Toxicology and Pharmacology 34, 249-257.
6. Dean, J.H., Twerdok, L.E., Tice, R.R., Sailstad, D.M., Hattan, D.G. & Stokes, W.S. (2001). ICCVAM evaluation of the murine local lymph node assay. II. Conclusions and recommendations of an independent scientific peer review panel. Regulatory Toxicology and Pharmacology 34, 258-273.
7. Haneke, K.E., Tice, R.R., Carson, B.L., Margolin, B.H. & Stokes, W.S. (2001). ICCVAM evaluation of the murine local lymph node assay. III. Data analysis completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods. Regulatory Toxicology and Pharmacology 34, 274-286.
8. EU (2004). Commission Directive 2004/73/EC of 29 April 2004 adapting to technical progress for the 29th time Council Directive 67/548/EEC on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Official Journal of the European Union L152, 1-316.
9. OECD (2002). OECD Guidelines for the Testing of Chemicals, No. 429: Skin Sensitisation: Local Lymph Node Assay, 7pp. Paris, France: Organisation for Economic Cooperation and Development.
10. Asherson, G.L. & Ptak, W. (1968). Contact and delayed hypersensitivity in the mouse. I. Active sensitization and passive transfer. Immunology 15, 405-410.
11. Gad, S.C., Dunn, B.J., Dobbs, D., Reilly, C. & Walsh, R.D. (1986). Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST). Toxicology and Applied Pharmacology 84, 93-114.
12. Gad, S.C. (1994). The mouse ear swelling test (MEST) in the 1990s. Toxicology 93, 33-46.
13. Cornacoff, J.B., House, R.V. & Dean, J.H. (1988). Comparison of a radioisotopic method and the mouse ear swelling test (MEST) for contact sensitivity to weak sensitizers. Fundamental and Applied Toxicology 10, 40-44.
14. Descotes, J. (1988). Identification of contact allergens: the mouse ear sensitization assay. Journal of Toxicology - Cutaneous and Ocular Toxicology 7, 263-272.
15. Dunn, B.J., Rusch, G.M., Siglin, J.C. & Blaszcak, D.L. (1990). Variability of a mouse ear swelling test (MEST) in predicting weak and moderate contact sensitization. Fundamental and Applied Toxicology 15, 242-248.
16. Gad, S.C., Dobbs, D.W., Dunn, B.J., Reilly, C., Walsh, R.D., Auletta, C.S., Hile, R.A., Reagan, E. & Yenser, B. (1987). Interlaboratory validation test (MEST). In Alternative Methods in Toxicology, Vol. 5, In Vitro Toxicology: Approaches to Validation (ed. A.M. Goldberg), pp. 275-292. New York, USA: Mary Ann Liebert.
17. Magnusson, B. & Kligman, A.M. (1969) The identification of contact allergens by animal assay. The guinea pig maximization test. Journal of Investigative Dermatology 52, 268-276.
18. Magnusson, B. & Kligman, A.M. (1970). Allergic Contact Dermatitis in the Guinea Pig, 141pp. Springfield, Illinois, USA: Charles C. Thomas.
19. OECD (1992). OECD Guidelines for the Testing of Chemicals, No. 406: Skin Sensitisation, 9pp. Paris, France: Organisation for Economic Cooperation and Development.
20. Buehler, E.V. (1965). Delayed contact hypersensitivity in the guinea pig. Archives of Dermatology 91, 171-177.
21. Schwartz, L. & Peck, S.M. (1944). The patch test in contact dermatitis. Public Health Reports 59, 546-557.
22. Schwartz, L. (1951). The skin testing of new chemicals. Journal of the Society of Cosmetic Chemists 2, 321-324.
23. Schwartz, L. (1969). Twenty-two years' experience in the performance of 200,000 prophetic patch tests. Southern Medical Journal 53, 478-484.
24. Draize, J.H., Woodard, G. & Calvery, H.D. (1944). Methods for the study of irritation and toxicology of substances applied topically to the skin and mucous membrane. Journal of Pharmacology and Experimental Therapeutics 83, 377-390.
25. Draize, J.H. (1959). Dermal toxicity. Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics, 3rd printing, 1975, pp. 46-59. Texas State Department of Health, Austin, TX, USA: Association of Food and Drug Officials of the United States.
26. Shelanski, H.A. (1951). Experience with and considerations of the human patch test method. Journal of the Society of Cosmetic Chemists 2, 324-331.
27. Shelanski, H.A. & Shelanski, W.V. (1953). A new technique of human patch tests. Proceedings of the Scientific Section of the Toilet Goods Association 19, 46-49.
28. Voss, J.G. (1958). Skin sensitization by mercaptans of low molecular weight. Journal of Investigative Dermatology 31, 273-279.
29. Griffith, J.F. & Buehler, E. (1976). Prediction of skin irritancy and sensitization potential by testing with animals and man. In Cutaneous Toxicity (ed. V. Drill & P. Lazer), pp. 177-173. New York, NY, USA: Academic Press.
30. Marzulli, F.N. & Maibach, H.I. (1973). Antimicrobials: experimental contact sensitisation in man. Journal of the Society of Cosmetic Chemists 24, 399-421.
31. Kligman, A.M. (1966). The identification of contact allergens by human assay. III. The maximisation test: a procedure for screening and rating contact sensitisers. Journal of Investigative Dermatology 47, 393-409.
32. Kligman, A.M. & Epstein, W. (1975). Updating the maximisation test for identifying contact allergens. Contact Dermatitis 1, 231-239.
33. Roberts, D.W. & Williams, D.L. (1982). The derivation of quantitative correlations between skin sensitisation and physico-chemical parameters for alkylating agents, and their application to experimental data for sultones. Journal of Theoretical Biology 99, 807-825.
34. Barratt, M.D., Basketter, D.A. & Roberts, D.W. (1997). Quantitative structure activity relationships. In The Molecular Basis of Allergic Contact Dermatitis (ed. J-P. LePoittevin, D.A. Basketter, A. Dooms-Goossens & A-T. Karlberg), pp. 129-154. Heidelberg, Germany: Springer-Verlag.
35. Cronin, M.T., Jaworska, J.S., Walker, J.D., Comber, M.H., Watts, C.D. & Worth, A.P. (2003). Use of QSARs in international decision-making frameworks to predict health effects of chemical substances. Environmental Health Perspectives 111, 1391-1401.
36. Sanderson, D.M. & Earnshaw, G.G. (1991). Computer prediction of possible toxic action from chemical structure: the DEREK system. Human and Experimental Toxicology 10, 261-273.
37. Ridings, J.E., Barratt, M.D., Cary, R., Earnshaw, C.G., Eggington, C.E., Ellis, M.K., Judson, P.N., Langowski, J.J., Marchant, C.A., Payne, M.P., Watson, W.P. & Yih, T.D. (1996). Computer prediction of possible toxic action from chemical structure: an update on the DEREK system. Toxicology 106, 267-279.
38. Enslein, K., Gombar, V.K., Blake, B.W., Maibach, H.I., Hostynek, J.J., Sigman, C.C. & Bagheri, D. (1997). A quantitative structure-toxicity relationship model for the dermal sensitization guinea pig maximization assay. Food and Chemical Toxicology 35, 1091-1098.
39. Gealy, R., Graham, C., Sussman, N.B., Macina, O.T., Rosenkranz, H.S. & Karol, M.H. (1996). Evaluating clinical case report data for SAR modeling of allergic contact dermatitis. Human and Experimental Toxicology 15, 489-493.
40. Walker, J.D., Carlsen, L., Hulzebos, E. & Simon-Hettich, B. (2002). Global government application of analogues, SARs and QSARs to predict aquatic toxicity, chemical or physical poperties, environmental fate parameters and health effects of organic chemicals. SAR and QSAR in Environmental Research 13, 607-616.
41. OECD (2002). OECD Database on Chemical Risk Assessment Models. Paris, France: Organisation for Economic Cooperation and Development. Website http://webdomino1.oecd.org/comnet/env/models.nsf.
42. Cronin, M.T. & Basketter, D.A. (1994). Multivariate QSAR analysis of a skin sensitization database. SAR and QSAR in Environmental Research 2, 159-179.
43. Barratt, M.D. & Langowski, J.J. (1999). Validation and subsequent development of the DEREK skin sensitization rulebase by analysis of the BgVV list of contact allergens. Journal of Chemical Information and Computer Sciences 39, 294-298.
44. Barratt, M.D. (1995). Quantitative structure activity relationships for skin corrosivity of organic acids, bases and phenols. Toxicology Letters 75, 169-176.
45. Zinke, S., Gerner, I. & Schlede, E. (2002). Evaluation of a rule base for identifying contact allergens by using a regulatory database: comparison of data on chemicals notified in the European Union with "structural alerts" used in the DEREK expert system. ATLA 30, 285-298.
46. Ryan, C.A., Hulette, B.C. & Gerberick G.F. (2001). Approaches for the development of cell-based in vitro methods for contact sensitization. Toxicology in Vitro 15, 43-55.
47. Matsue, H., Cruz, P.D., Bergstresser, P.R. & Takashima, A. (1992). Cytokine expression by epidermal cell subpopulations. Journal of Investigative Dermatology 99, 42S-45S.
48. Schwarz, T. & Luger, T.A. (1992). Pharmacology of cytokines in the skin. In Pharmacology of the Skin (ed. H. Mukhtar), pp. 283-313. Boca Raton, FL, USA: CRC Press.
49. Wilmer, J.L., Burleson, F.G., Kayama, F., Kanno, J. & Luster, M.I. (1994). Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin. Journal of Investigative Dermatology 102, 915-922.
50. Pastore, S., Shivji, G.M., Kondo, S., Kono, T., McKenzie, R.C., Segal, L., Somers, D. & Sauder, D.N. (1995). Effects of contact sensitizers neomycin sulfate, benzocaine and 2,4-dinitrobenzene 1-sulfonate, sodium salt on viability, membrane integrity and IL-1α mRNA expression of cultured normal human keratinocytes. Food and Chemical Toxicology 33, 57-68.
51. Corsini, E., Primavera, A., Marinovich, M. & Galli, C.L. (1998). Selective induction of cell-associated interleukin-1α in murine keratinocytes by chemical allergens. Toxicology 129, 193-200.
52. Coutant, K.D., Ulrich, P., Thomas, H., Cordier, A. & de Brugerolle de Fraissinette, A. (1999). Early changes in murine epidermal cell phenotype by contact sensitizers. Toxicological Sciences 48, 74-81.
53. Wakem, P., Burns, R.P., Ramirez, F., Zlotnick, D., Ferbel, B., Haidaris, C.G. & Gaspari, A.A. (2000). Allergens and irritants transcriptionally upregulate CD80 gene expression in human keratinocytes. Journal of Investigative Dermatology 114, 1085-1092.
54. Lozsekova, A., Kaiser, H.W., Danilla, T., Buchvald, J. & Simko, J. (2002). The effect of nickel sulfate, potassium dichromate, cobalt nitrate and cadmium sulphate on the proteins of cellular contacts and actin skeleton of cultivated human keratinocytes. Bratislavske Lekarske Listy 103, 254-259.
55. Hanau, D., Schmitt, D.A., Fahre, M. & Cazenave J.P. (1988). A method for the rapid isolation of human epidermal Langerhans cells using immunomagnetic microspheres. Journal of Investigative Dermatology 91, 274-279.
56. Koch, F., Kämpgen, E., Schuler, G. & Romani, R. (1992). Effective enrichment of murine epidermal Langerhans cells by a modified (mismatched) panning technique. Journal of Investigative Dermatology 99, 803-807.
57. Simon, J.C., Dittmar, H.C., de Roche, R., Wilting, J., Christ, B. & Schopf, E. (1995). Rapid purification of human Langerhans cells using paramagnetic microbeads. Experimental Dermatology 4, 155-161.
58. Teunissen, M.B., Wormmeester, J., Kapsenberg, M.L. & Bos, J.D. (1988). Enrichment of unlabeled human Langerhans cells from epidermal cell suspensions by discontinuous density gradient centrifugation. Journal of Investigative Dermatology 91, 358-362.
59. Aiba, S. & Katz, S.I. (1990). Phenotypical and functional characteristics of in vivo-activated Langerhans cells. Journal of Immunology 145, 2791-2796.
60. Schwarzenberger, K. & Udey, M.C. (1996). Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. Journal of Investigative Dermatology 106, 553-558.
61. Herouet, C., Cottin, M., Galanaud, P., Leclaire, J. & Rousset, F. (1999). Contact sensitizers decrease 33D1 expression on mature Langerhans cells. European Journal of Dermatology 9, 185-190.
62. Verrier, A.C., Schmitt, D. & Staquet, M.J. (1999). Fragrance and contact allergens in vitro modulate the HLA-DR and E-Cadherin expression on human epidermal Langerhans cells. International Archives of Allergy and Immunology 120, 56-62.
63. Tuschl, H. & Kovac, R. (2001). Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers. Toxicology in Vitro 15, 327-331.
64. Girolomoni, G., Cruz, P.D. & Bergstresser, P.R. (1990). Internalization and acidification of surface HLA-DR molecules by epidermal Langerhans cells: a paradigm for antigen processing. Journal of Investigative Dermatology 94, 753-760.
65. Becker, D., Mohamadzadeh, M., Reske, K. & Knop, J. (1992). Increased level of intracellular MHC class II molecules in murine Langerhans cells following in vivo and in vitro administration of contact allergens. Journal of Investigative Dermatology 99, 545-549.
66. Becker, D., Neis, U., Neis, S., Reske, K. & Knop, J. (1992). Contact allergens modulate the expression of MHC class II molecules on murine epidermal Langerhans cells by endocytic mechanisms. Journal of Investigative Dermatology 98, 700-705.
67. Lempertz, U., Kühn, U., Knop, J. & Becker, D. (1996). An approach to predictive testing of contact sensitizers in vitro by monitoring their influence on endocytic mechanisms. International Archives of Allergy and Immunology 111, 64-70.
68. Rizova, H., Carayon, P., Barbier, A., Lacheretz, F., Dubertret, L. & Michel, L. (1999). Contact allergens, but not irritants, alter receptor-mediated endocytosis by human epidermal Langerhans cells. British Journal of Dermatology 140, 200-209.
69. Kühn, U., Brand, P., Willemsen, J., Jonuleit, H., Enk, A.H., van Brandwijk-Petershans, R., Saloga, J., Knop, J. & Becker, D. (1998). Induction of tyrosine phosphorylation in human MHC class II-positive antigen-presenting cells by stimulation with contact sensitizers. Journal of Immunology 160, 667-673.
70. Neisius, U., Brand, P., Plochmann, S., Saloga, J., Knop, J. & Becker, D. (1999). Detection of increased tyrosine phosphorylation in murine Langerhans cells after stimulation with contact sensitizers. Archives of Dermatological Research 291, 22-27.
71. Kripke, M.L., Munn, C.G., Jeevan, A., Tang, J.M. & Bucana, C. (1990). Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. Journal of Immunology 145, 2833-2838.
72. Macatonia, S.E., Knight, S.C., Edwards, A.J., Griffiths, S. & Fryer, P. (1987). Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Journal of Experimental Medicine 166, 1654-1667.
73. Kobayashi, Y., Staquet, M-J., Dezutter-Dambuyant, C. & Schmitt, D. (1994). Development of motility of Langerhans cell through extracellular matrix by in vitro hapten contact. European Journal of Immunology 24, 2254-2257.
74. Romani, N., Gruner, S., Brang, D., Kampgen, E., Lenz, A., Trockenbacher, B., Konwalinka, G., Fritsch, P.O., Steinman, R.M. & Schuler, G. (1994). Proliferating dendritic cell progenitors in human blood. Journal of Experimental Medicine 180, 83-93.
75. Degwert, J., Steckel, F., Hoppe, U. & Kligman, H. (1997). In vitro model for contact sensitization. I. Stimulatory capacities of human blood-derived dendritic cells and their phenotypical alterations in the presence of contact sensitizers. Toxicology in Vitro 11, 613-618.
76. Aiba, S., Terunuma, A., Manome, H. & Tagami, H. (1997). Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. European Journal of Immunology 27, 3031-3038.
77. Coutant, K.D., de Brugerolle de Fraissinette, A., Cordier, A. & Ulrich, P. (1999). Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicological Sciences 52, 189-198.
78. Rougier, N., Redziniak, G., Mougin, D., Schmitt, D. & Vincent, C. (2000). In vitro evaluation of the sensitization potential of weak contact allergens using Langerhans-like dendritic cells and autologous T cells. Toxicology 145, 73-82.
79. Hulette, B.C., Ryan, C.A. & Gerberick, G.F. (2002). Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment. Toxicology and Applied Pharmacology 182, 226-233.
80. Hulette, B.C., Rowden, G., Ryan, C.A., Lawson, C.M., Dawes, S.M., Ridder, G.M. & Gerberick, G.F. (2001). Cytokine induction of a human acute myelogenous leukemia cell line (KG-1) to a CD1α+ dendritic cell phenotype. Archives of Dermatology Research 293, 147-158.
81. Banerjee, G., Iyer, V.J. & Cherian, K.M. (2003). A rapid in vitro method of identifying contact allergens and irritants. Toxicology Mechanisms and Methods 13, 103-109.
82. Becker, D., Kuhn, U., Lempertz, U., Enk, A., Saloga, J. & Knop, J. (1997). Flow-cytometric screening for the modulation of receptor-mediated endocytosis in human dendritic cells: implications for the development of an in vitro technique for predictive testing of contact sensitizers. Journal of Immunological Methods 203, 171-180.
83. Enk, A.H. & Katz, S.I. (1992). Early molecular events in the induction phase of contact sensitivity. Proceedings of the National Academy of Sciences USA 89, 1398-1402.
84. Enk, A.H., Angeloni, V.L., Udey, M.C. & Katz, S.I. (1993). An essential role or Langerhans cell-derived IL-1b in the initiation of primary immune responses in skin. Journal of Immunology 150, 3698-3704.
85. Reutter, K., Jager, D., Degwert, J. & Hoppe, U. (1997). In vitro model for contact sensitization. II. Induction of IL-1b mRNA in human blood-derived dendritic cells by contact sensitizers. Toxicology in Vitro 11, 619-626.
86. De Smedt, A.C., Van Den Heuvel, R.L., Swi Berneman, N. & Schoeters, G.E. (2001). Modulation of phenotype, cytokine production and stimulatory function of CD34+-derived DC by NiCl(2) and SDS. Toxicology in Vitro 15, 319-325.
87. De Smedt, A.C., Van Den Heuvel, R.L., Van Tendeloo, V.F., Berneman, Z.N., Schoeters, G.E., Weber, E. & Tuschl, H. (2002). Phenotypic alterations and IL-1 beta production in CD34(+) progenitor- and monocyte-derived dendritic cells after exposure to allergens: a comparative analysis. Archives of Dermatological Research 294, 109-116.
88. Pichowski, J.S., Cumberbatch, M., Dearman, R.J., Basketter, D.A. & Kimber, I. (2000). Investigation of induced changes in interleukin 1b mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing. Toxicology in Vitro 14, 351-360.
89. Pichowski, J.S., Cumberbatch, M., Dearman, R.J., Basketter, D.A. & Kimber, I. (2001). Allergen-induced changes in interleukin 1 beta (IL-1 beta) mRNA expression by human blood-derived dendritic cells: inter-individual differences and relevance for sensitization testing. Journal of Applied Toxicology 21, 115-121.
90. Aeby, P., Wyss, C., Beck, H., Griem, P., Scheffler, H. & Goebel, C. (2004). Characterization of the sensitising potential of chemicals by in vitro analysis of dendritic cell activation and skin penetration. Journal of Investigative Dermatology 122, 1154-1164.
91. Lore, K., Sonnerborg, A., Spetz, A.L., Andersson, U. & Andersson, J. (1998). Immunocytochemical detection of cytokines and chemokines in Langerhans cells and in vitro derived dendritic cells. Journal of Immunological Methods 214, 97-111.
92. Aiba, S. & Tagami, H. (1999). Dendritic cells play a crucial role in innate immunity to simple chemicals. Journal of Investigative Dermatology Symposium Proceedings 4, 158-163.
93. Xu, S., Ariizumi, K., Caceres-Dittmar, G., Edelbaum, D., Hashimoto, K., Bergstresser, P.R. & Takashima, A. (1995). Successive generation of antigen-presenting, dendritic cell lines from murine epidermis. Journal of Immunology 154, 2697-2705.
94. Ariizumi, K., Kitajima, T., Bergstresser, P.R. & Takashima, A. (1995). Interleukin-1b converting enzyme in murine Langerhans cells and epidermal-derived dendritic cell lines. European Journal of Immunology 25, 2137-2141.
95. Takashima, A., Edelbaum, D., Kitajima, R., Shadduck, K., Gilmore, G.L., Xu, S., Taylor, R.S., Bergstresser, P.R. & Ariizumi, K. (1995). Colony-stimulating factor-1 secreted by fibroblasts promotes the growth of dendritic cell lines (XS series). Journal of Immunology 154, 5128-5135.
96. Xu, S., Ariizumi, K., Edelman, D., Bergstresser, P.R. & Takashima, A. (1995). Cytokine-dependent regulation of growth and maturation in murine epidermal dendritic cell lines. European Journal of Immunology 25, 1018-1024.
97. Kitajima, T., Ariizumi, K., Mohamadazadeh, M., Edelbaum, D., Bergstresser, P.R. & Takashima, A. (1995). T cell-dependent secretion of IL-1b by a dendritic cell line (XS52) derived from murine epidermis. Journal of Immunology 155, 3794-3800.
98. + cell line (XS52) by IL-4, TNF-a, IL-1b, and agonistic anti-CD40 monoclonal antibody. Journal of Immunology 163, 5331-5337.
99. Yoshida, Y., Sakaguchi, H., Ito, Y., Okuda, M. & Suzuki, H. (2003). Evaluation of the skin sensitization potential of chemicals using expression of costimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. Toxicology in Vitro 17, 221-228.
100. Ashikaga, T., Hoya, M., Itagaki, H., Katsumura, Y. & Aiba, S. (2002). Evaluation of CD86 expression and MHC class II molecule internalization in THP-1 human monocyte cells as predictive endpoints for contact sensitizers. Toxicology in Vitro 16, 711-716.
101. Hauser, C. & Katz, S.I. (1988). Activation and expansion of hapten- and protein-specific T helper cells from nonsensitized mice. Proceedings of the National Academy of Sciences USA 85, 5625-5628.
102. Moulon, C., Péguet-Navarro, J., Courtellemont, P., Redziniak, G. & Schmitt, D. (1993). In vitro primary sensitization and re-stimulation of hapten-specific T cells by fresh and cultured human epidermal Langerhans cells. Immunology 80, 373-379.
103. Krasteva, M., Peguet-Navarro, J., Moulon, C., Courtellemont, P., Redziniak, G. & Schmitt, D. (1996). In vitro primary sensitization of hapten-specific T cells by cultured human epidermal Langerhans cells: a screening predictive assay for contact sensitizers. Clinical and Experimental Allergy 26, 563-570.
104. Régnier, M., Staquet, M.J., Schmitt, D. & Schmidt, R. (1997). Integration of Langerhans cells into a pigmented reconstructed human epidermis. Journal of Investigative Dermatology 109, 510-512.
105. Facy, V., Flouret, V., Régnier, M. & Schmidt, R. (2004). Langerhans cells integrated into human reconstructed epidermis respond to known sensitizers and UV-exposure. Journal of Investigative Dermatology 122, 552-553.
106. Kobel, M.A., Limat, A., Mauri, D., Braathen, L.R. & Hunziker, T. (1996). Primary sensitization of human T lymphocytes by cytokine-cultured, peripheral blood monocytes. European Journal of Dermatology 6, 409-413.
107. Dai, R. & Streilein, J.W. (1998). Naïve, hapten-specific human T lymphocytes are primed in vitro with derivatized blood mononuclear cells. Journal of Investigative Dermatology 110, 29-33.
108. Rougier, N., Redziniak, G., Schmitt, D. & Vincent, C. (1998). Evaluation of the capacity of dendritic cells derived from cord blood CD34+ precursors to present haptens to unsensitized autologous T cells in vitro. Journal of Investigative Dermatology 110, 348-352.
109. Rustemeyer, T., De Ligter, S., Von Blomberg, M.E., Frosch, P.J. & Scheper, R.J. (1999). Human T lymphocyte priming in vitro by haptenated autologous dendritic cells. Clinical and Experimental Immunology 117, 209-216.
110. Yokozeki, H., Katayama, I. & Nishioka, K. (1995). Experimental study for the development of an in vitro test for contact allergens. I. Primary activation of hapten-specific T cells by hapten-conjugated epidermal cells. International Archives of Allergy and Immunology 106, 394-400.
111. Arimura, M., Yokozeki, H., Katayama, I., Nakamura, T., Masuda, M. & Nishioka, K. (1998). Experimental study for the development of an in vitro test for contact allergens. II. Comparison of the in vitro sensitization test with the guinea pig maximization test for contact allergens. International Archives of Allergy and Immunology 115, 228-234.
112. Kubilus, J., Cannon, C., Neal, P., Sennott, H. & Klausner, M. (1996). Response of the EpiDerm skin model to topically applied irritants and allergens. In Vitro Toxicology 9, 157-166.
113. Coquette, A., Berna, N., Vandenbosch, A., Rosdy, M. & Poumay, Y. (1999). Differential expression and release of cytokines by an in vitro reconstructed human epidermis following exposure to skin irritant and sensitizing chemicals. Toxicology in Vitro 13, 867-877.
114. Coquette, A., Berna, N., Vandenbosch, A., Rosdy M., De Wever, B. & Poumay, Y. (2003). Analysis of interleukin-1α (IL-1α) and interleukin-8 (IL-8) expression and release in in vitro reconstructed human epidermis for the prediction of in vivo skin irritation and/or sensitization. Toxicology in Vitro 17, 311-321.
115. Gerberick, G.F. & Sikorski, E.E. (1998). In vitro and in vivo testing techniques for allergic contact dermatitis. American Journal of Contact Dermatitis 9, 111-118.
116. Corsini, E., Limiroli, E., Marinovich, M., Cohen, C., Rouget, R. & Galli, C.L. (1999). Selective induction of interleukin-12 in reconstructed human epidermis by chemical allergens. ATLA 27, 261-269.
117. Pistoor, F.H.M., Rambukkana, A., Kroezen, M., Lepoittevin, J-P., Bos, J.D., Kapsenberg, M.L. & Das, P.K. (1996). Novel predictive assay for contact allergens using human skin explant cultures. American Journal of Pathology 149, 337-343.
118. Lukas, M., Stössel, H., Hefel, L., Imamura, S., Fritsch, P., Sepp, N.T., Schuler, G. & Romani, N. (1996). Human cutaneous dendritic cells migrate through dermal lymphatic vessels in a skin organ culture model. Journal of Investigative Dermatology 106, 1293-1299.
119. Rambukkana, A., Pistoor, F.H.M., Bos, J.D., Kapsenberg, M.L. & Das, P.K. (1996). Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1β protein. Laboratory Investigations 74, 442-436.